Drug Topics

JULY 13, 2023

Pharmacists can utilize AI for medication management and to prevent medication errors.

182

182

Pharmacy Times

JULY 13, 2023

The approval of norgestrel tablets (Opill) could open the door to other prescription-to-OTC contraceptive switches, although that remains to be seen as other pharmaceutical companies weigh their options.

Pharmaceutical Companies 123

Pharmaceutical Companies Pharmaceutical Companies FDA 123

Drug Topics

JULY 13, 2023

The news comes almost 2 weeks after Cyltezo’s entrance into the US biosimilars market as the first commercially available and FDA-approved interchangeable adalimumab biosimilar.

FDA 98

FDA 98

Pharmacy Times

JULY 13, 2023

Impact of healthy eating was especially evident in countries where consumption of these foods is low, which elevates the risk for cardiovascular disease, including heart attacks and strokes.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

JULY 13, 2023

The approval of norgestrel (Opill) is expected to help reduce barriers to access by allowing people to obtain the medication without needing to see a health care provider.

FDA 98

FDA 98

Pharmacy Times

JULY 13, 2023

Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is an example of the expanding role of pharmacists and their contribution to primary care practice.

Vaccines 123

Vaccines Patient Care 123

Pharmacy Times

JULY 13, 2023

Irreversible Bruton tyrosine kinase inhibitor produces positive results in patients with relapsed/refractory marginal zone lymphoma.

123

123

STAT

JULY 13, 2023

It’s been a year since the U.S. launched its 988 national mental health hotline — and while the service is still dealing with logistical challenges , its biggest issue may be persuading more Americans to make use of it. Only 33% of Americans are at least somewhat familiar with the number and the service it provides, according to a survey of more than 2,000 adults conducted by Ipsos and the National Alliance on Mental Illness (NAMI) conducted in June 2023.

98

98

Pharmacy Times

JULY 13, 2023

MicroRNA has shown the potential to more effectively and accurately identify C. difficile infections and manage it after diagnosis.

123

123

STAT

JULY 13, 2023

By going down to the molecular level, doctors have uncovered a way to treat tumors caused by a rare brain cancer using medicines that already exist. Two cancer drugs — currently approved for the treatment of melanoma — were able to treat a rare type of brain cancer called PCP, or papillary craniopharyngioma, researchers reported in a study published Thursday in the New England Journal of Medicine.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JULY 13, 2023

A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.

116

116

Fierce Pharma

JULY 13, 2023

With the multiple sclerosis market growing rapidly—from $18.9 billion in 2020 to a projec | A phase 3 study has shown that a new, subcutaneous version of Roche's Ocrevus has proven to be non-inferior to the current infused treatment as measured by the level of drug in the blood, 12 weeks after administration. An approval for the injected version would allow patients to receive treatment in 10 minutes as opposed to four hours, every six months.

98

98

Pharmacy Times

JULY 13, 2023

Evidence remains limited for specific therapies to treat the disease, but new clinical trials are ongoing.

123

123

STAT

JULY 13, 2023

WASHINGTON — Aspartame, the popular artificial sweetener in diet sodas and chewing gums, may possibly cause cancer — but the risk appears to be very low for occasional consumers of these products, according to two reports released Thursday evening by the World Health Organization. The first report , penned by the WHO’s International Agency for Research on Cancer (IARC), found “limited evidence” that aspartame may cause liver cancer.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

JULY 13, 2023

Approximately 22% of gross Medicare Part D spending can be attributed to 10 top-selling prescription drugs, according to analysis from KFF. | A new analysis shows a small number of prescription drugs disproportionately make up Medicare Part D spending.

98

98

Pharma Marketing Network

JULY 13, 2023

When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.

98

98

Fierce Healthcare

JULY 13, 2023

The Centers for Medicare & Medicaid Services (CMS) is recommending preexposure prophylaxis (PrEP) with oral or injectable antiretroviral therapy to people at risk of HIV without patient cost sh | A new proposal would allow Medicare beneficiaries to protect themselves against HIV without cost-sharing through preexposure prophylaxis and antiretroviral therapy.

98

98

STAT

JULY 13, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

FDA 98

FDA 98

Fierce Healthcare

JULY 13, 2023

Hospital merger and acquisition deal volume has returned to pre-pandemic levels as of the second quarter of 2023, according to a new roundup report. | Twenty new hospital merger and acquisition deals were unveiled during the second quarter of 2023, the most since 2018.

Hospitals 98

Hospitals 98

Fierce Pharma

JULY 13, 2023

After a full FDA approval last week triggered Medicare coverage of Eisai and Biogen’s Leqembi, doctors are still trying to work out the logistics of testing and reimbursement. | After a full FDA approval last week triggered Medicare coverage of Eisai and Biogen’s Leqembi, doctors are still working out the logistics of testing and reimbursement. But at least two experts remain positive about the drug’s efficacy and safety profile.

FDA 98

FDA 98

STAT

JULY 13, 2023

In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the  lowest numbers  of new HIV diagnoses in decades. New HIV infections were down 12% from 2017 to 2021, thanks to successful prevention efforts, including PrEP. The end of the epidemic may finally be in our grasp. Prevention methods now include a medication called PrEP (for pre-exposure prophylaxis), and uptake has never been higher.

98

98

Fierce Healthcare

JULY 13, 2023

The Centers for Medicare & Medicaid Services has released its proposed Medicare payment rates and policy updates under the Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory S | The CY 2024 OPPS and ASC Payment System Proposed Rule includes a 2.8% pay increase for facilities, hospital price transparency updates and more.

Hospitals 98

Hospitals 98

Pharma Marketing Network

JULY 13, 2023

The pharmaceutical industry is a highly regulated industry, and as such, marketing strategies must be carefully planned and executed. However, this does not mean that out-of-the-box marketing is not possible or effective. In fact, in some cases, out-of-the-box marketing can be the most effective way to reach target audiences and achieve marketing goals.

98

98

Fierce Healthcare

JULY 13, 2023

A key House panel has advanced yet another legislative package that aims to inject greater transparency into healthcare, particularly for pharmacy benefit managers. | A key House panel has advanced yet another legislative package that aims to inject greater transparency into healthcare, particularly for pharmacy benefit managers.

Packaging 98

Packaging 98

Fierce Pharma

JULY 13, 2023

CureVac is adding fuel to its COVID-19 vaccine patent fire by asserting more claims against Pfizer and BioNTech in both its U.S. and German cases. | CureVac is adding more fuel to the fire in its COVID-19 patent cases against Pfizer and fellow German mRNA maker BioNTech, adding a tenth claim in its U.S. dispute and three to its suit in Germany.

Vaccines 98

Vaccines 98

STAT

JULY 13, 2023

Health systems drowning in messages from patients are grasping for new ways to manage the deluge — including charging for especially time-consuming responses. In recent months, health systems including Cleveland Clinic and University of Washington have trotted out new billing policies for when patient portal questions require more than just a few minutes of a provider’s time — an attempt to compensate for staff time spent while also stanching the breakneck response pace pati

Hospitals 98

Hospitals Insurance 98

Hospital Pharmacy Europe

JULY 13, 2023

Nearly two-thirds of UK qualified pharmacists reported not feeling confident at identifying drugs that required pharmacogenomic testing , a recent survey by researchers at the University of Liverpool has found. Using a cross-sectional methodological approach, researchers gathered anonymised data from registered, preregistration and student pharmacists in the UK to ascertain the current educational status of pharmacogenomics.

Hospitals 97

Hospitals 97

Fierce Pharma

JULY 13, 2023

BeiGene lost its TIGIT inhibitor collaboration with Novartis but signed an antibody-drug conjugate deal with Duality Biologics. | Novartis walked away from BeiGene's TIGIT inhibitor. Takeda pulled the FDA filing for its dengue vaccine after the FDA requested more data. Eisai's Alzheimer's chief Ivan Cheung is handing the baton to group CEO's son.

FDA 97

FDA Vaccines 97

Pharma Marketing Network

JULY 13, 2023

Your website is your online storefront, so it’s important to choose the best web development company to create it. In the pharmaceutical industry, where trust and credibility are essential, it’s especially important to choose a web development company that understands the specific needs of your business. Here are some factors to consider when choosing a web development company for the pharmaceutical industry: ● Experience in the pharmaceutical industry: Make sure the company you choo

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Communication 97

STAT

JULY 13, 2023

After leaving his post as the head of research at Bristol Myers Squibb, Rupert Vessey is joining venture firm Flagship Pioneering. Vessey will become an executive partner and chief scientist at Flagship starting July 31, according to a press release. He will work with the teams at Flagship that create new startups, helping them with science and R&D strategies.

97

97

Hospital Pharmacy Europe

JULY 13, 2023

NICE appraised 70% more medicines in 2022/23 than in 2019/20, which has led to faster access to medicines, its chief executive has said. This follows a new ‘proportionate approach’ to technology appraisals introduced last year to increase capacity. By simplifying, removing, or reconfiguring parts of the appraisals process, NICE said it can do light-touch, faster evaluations to simpler, low-risk treatments to speed up its guidance.

Hospitals 97

Hospitals 97

STAT

JULY 13, 2023

In the 1930s, the U.S. government introduced the practice of redlining — categorizing neighborhoods based on the ethnic and racial backgrounds of the people who lived there, with areas primarily occupied by people of color identified as high-risk for mortgage lenders. The policy led to further housing segregation and decades of disinvestment in health care, schools, and other basic services and infrastructure, taking a disproportionate toll on Black communities.

97

97

European Pharmaceutical Review

JULY 13, 2023

In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The CDMO’s Carrie Mason shared that PAT, “takes a little bit more time and more effort and more capital to set up in the beginning, but once you get it up and running it’s very continuous and it should continue to provide results for a long time”.

96

96

STAT

JULY 13, 2023

WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by. Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

Chemotherapy 96

Chemotherapy 96